CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 
 

BTCY's Net Income Growth by Quarter and Year

Biotricity Inc 's Net Income results by quarter and year




BTCY Net Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - -4.52 -7.11 -3.90
III Quarter December -2.81 -4.69 -10.75 -2.96
II Quarter September -3.41 -4.78 -5.66 -3.16
I Quarter June -4.67 -5.61 -5.47 -4.60
FY   -10.89 -19.60 -28.99 -14.62



BTCY Net Income third quarter 2024 Y/Y Growth Comment
Biotricity Inc in the third quarter 2024 recorded net loss of $ -2.81 millions.

According to the results reported in the third quarter 2024, Biotricity Inc achieved the best Net Income growth in Medical Equipment & Supplies industry. While Biotricity Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2024.




BTCY Net Income ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Biotricity Inc 's third quarter 2024 Net Income $ -2.81 millions BTCY's Income Statement
Biotricity Inc 's third quarter 2023 Net Income $ -4.69 millions Quarterly BTCY's Income Statement
New: More BTCY's historic Net Income Growth >>


BTCY Net Income (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Biotricity Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Net Income Comment
Despite the fact, that Biotricity Inc in the III. Quarter 2024 revealed net loss of $ -2.81 millions, it should be point out, that this are slight up side relative to the -3.41 millions in the second quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Net Income growth. While Biotricity Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's III. Quarter Q/Q Net Income Comment
Even if Biotricity Inc in the III. Quarter 2024 showed net loss of $ -2.81 millions, management mentioned, that current results point to improvement relative to the -3.41 millions in the second quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Net Income growth. While Biotricity Inc 's Net Income growth quarter on quarter, overall rank is .


Biotricity Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -15.41 $ -17.29 $ -18.66 $ -19.60 $ -22.19
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
BTCY's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for BTCY's Competitors
Net Income Growth for Biotricity Inc 's Suppliers
Net Income Growth for BTCY's Customers

You may also want to know
BTCY's Annual Growth Rates BTCY's Profitability Ratios BTCY's Asset Turnover Ratio BTCY's Dividend Growth
BTCY's Roe BTCY's Valuation Ratios BTCY's Financial Strength Ratios BTCY's Dividend Payout Ratio
BTCY's Roa BTCY's Inventory Turnover Ratio BTCY's Growth Rates BTCY's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.08%$ -0.081 millions
Sanuwave Health Inc -0.23%$ -0.232 millions
Regeneron Pharmaceuticals Inc -3.13%$ -3.133 millions
Haemonetics Corporation-5.17%$ -5.169 millions
Resmed Inc -7.16%$ -7.165 millions
Edwards Lifesciences Corporation-7.20%$ -7.204 millions
Check cap Ltd -8.06%$ -8.059 millions
Star Equity Holdings Inc -9.48%$ -9.481 millions
Bristol myers Squibb Company-12.99%$ -12.988 millions
Gilead Sciences Inc -13.23%$ -13.227 millions
Utah Medical Products Inc-13.50%$ -13.499 millions
Alpha Tau Medical Ltd -13.64%$ -13.640 millions
Masimo Corp-17.13%$ -17.125 millions
Merit Medical Systems Inc-17.28%$ -17.281 millions
Fresenius Medical Care Ag-18.10%$ -18.099 millions
Qiagen N v -19.35%$ -19.354 millions
Mettler Toledo International Inc-30.49%$ -30.485 millions
Avantor Inc -30.49%$ -30.487 millions
Infusystem Holdings Inc-32.71%$ -32.710 millions
Grifols Sa-33.37%$ -33.368 millions
Sanofi-35.93%$ -35.926 millions
Icu Medical Inc-38.15%$ -38.151 millions
Ir med Inc -39.19%$ -39.187 millions
Amedisys Inc-39.71%$ -39.707 millions
Avanos Medical Inc -40.34%$ -40.341 millions
Embecta Corp -42.90%$ -42.898 millions
Pro dex Inc -43.12%$ -43.117 millions
American Shared Hospital Services-43.45%$ -43.450 millions
Becton Dickinson And Company-44.79%$ -44.794 millions
Bio techne Corp-45.08%$ -45.075 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com